Arxis, Inc.
ARXSSync financial data to generate a health grade for this company.
Analytical Summary
Review the statement evidence below to form a view on ARXS.
5-Year Financial Trajectory
QuarterlyStatement lens
Choose the reporting cadence, isolate a period range, or search directly for a metric.
| Metric | Q2 FY2026 Jun 30, 2026 10-Q ↗ | Q1 FY2026 Mar 31, 2026 10-Q ↗ | Q4 FY2025 Dec 31, 2025 10-Q ↗ | Q2 FY2025 Jun 30, 2025 10-Q ↗ | Q1 FY2025 Mar 31, 2025 10-Q ↗ |
|---|---|---|---|---|---|
| Revenue Growth YoY (%) |
25.0%
Excellent
Excellent
Year-over-year change in total revenue
Optimal:
> 10%
vs Sector:
Above avg (+401%)
|
20.7%
Excellent
Excellent
Year-over-year change in total revenue
Optimal:
> 10%
vs Sector:
Above avg (+315%)
|
— | — | — |
| Metric | Q2 FY2026 Jun 30, 2026 10-Q ↗ | Q1 FY2026 Mar 31, 2026 10-Q ↗ | Q4 FY2025 Dec 31, 2025 10-Q ↗ | Q2 FY2025 Jun 30, 2025 10-Q ↗ | Q1 FY2025 Mar 31, 2025 10-Q ↗ |
|---|---|---|---|---|---|
| Operating Margin (%) (%) |
6.5%
Caution
↓
Caution
Declining
Operating income as a percentage of revenue
Optimal:
> 15%
vs Sector:
Below avg (-46%)
|
24.1%
Good
↑
Good
Improving
Operating income as a percentage of revenue
Optimal:
> 15%
vs Sector:
Above avg (+101%)
|
— |
20.7%
Good
Good
Operating income as a percentage of revenue
Optimal:
> 15%
vs Sector:
Above avg (+72%)
|
15.8%
Fair
Fair
Operating income as a percentage of revenue
Optimal:
> 15%
vs Sector:
Above avg (+32%)
|
| Effective Tax Rate (%) (%) |
-247.2%
Excellent
↓
Excellent
Declining
Actual taxes paid relative to pre-tax income
Optimal:
15-25%
|
22.8%
Fair
↓
Fair
Declining
Actual taxes paid relative to pre-tax income
Optimal:
15-25%
|
— |
200.6%
Weak
Weak
Actual taxes paid relative to pre-tax income
Optimal:
15-25%
|
36.7%
Weak
Weak
Actual taxes paid relative to pre-tax income
Optimal:
15-25%
|
| Profit Margin (%) (%) |
10.6%
Fair
↑
Fair
Improving
Net income as a percentage of revenue
Optimal:
> 15%
vs Sector:
Above avg (+33%)
|
11.6%
Fair
↑
Fair
Improving
Net income as a percentage of revenue
Optimal:
> 15%
vs Sector:
Above avg (+45%)
|
— |
-1.1%
Weak
Weak
Net income as a percentage of revenue
Optimal:
> 15%
vs Sector:
Below avg (-113%)
|
-1.1%
Weak
Weak
Net income as a percentage of revenue
Optimal:
> 15%
vs Sector:
Below avg (-114%)
|
| FCF Margin (%) (%) |
27.5%
Excellent
↑
Excellent
Improving
Free cash flow as a percentage of revenue
Optimal:
> 10%
|
7.9%
Caution
↓
Caution
Declining
Free cash flow as a percentage of revenue
Optimal:
> 10%
|
— |
11.9%
Fair
Fair
Free cash flow as a percentage of revenue
Optimal:
> 10%
|
5.5%
Caution
Caution
Free cash flow as a percentage of revenue
Optimal:
> 10%
|
| FCF / Net Income (x) |
2.59x
Excellent
↑
Excellent
Improving
Free cash flow relative to reported net income
Optimal:
> 1x
|
0.68x
Weak
↑
Weak
Improving
Free cash flow relative to reported net income
Optimal:
> 1x
|
— |
-11.06x
Weak
Weak
Free cash flow relative to reported net income
Optimal:
> 1x
|
-4.80x
Weak
Weak
Free cash flow relative to reported net income
Optimal:
> 1x
|
| Metric | Q2 FY2026 Jun 30, 2026 10-Q ↗ | Q1 FY2026 Mar 31, 2026 10-Q ↗ | Q4 FY2025 Dec 31, 2025 10-Q ↗ | Q2 FY2025 Jun 30, 2025 10-Q ↗ | Q1 FY2025 Mar 31, 2025 10-Q ↗ |
|---|---|---|---|---|---|
| Return on Invested Capital (%) |
6.6%
Caution
Caution
Return earned on debt + equity capital invested
Optimal:
> 10%
|
3.2%
Weak
Weak
Return earned on debt + equity capital invested
Optimal:
> 10%
|
— | — | — |
| Return on Capital (%) (%) |
0.5%
Weak
Weak
Operating profit relative to total assets
Optimal:
> 10%
|
1.7%
Weak
Weak
Operating profit relative to total assets
Optimal:
> 10%
|
— | — | — |
| Metric | Q2 FY2026 Jun 30, 2026 10-Q ↗ | Q1 FY2026 Mar 31, 2026 10-Q ↗ | Q4 FY2025 Dec 31, 2025 10-Q ↗ | Q2 FY2025 Jun 30, 2025 10-Q ↗ | Q1 FY2025 Mar 31, 2025 10-Q ↗ |
|---|---|---|---|---|---|
| Interest Coverage (x) |
0.83x
Weak
↓
Weak
Declining
Operating income divided by interest expense
Optimal:
> 5x
|
2.51x
Caution
↑
Caution
Improving
Operating income divided by interest expense
Optimal:
> 5x
|
— |
1.44x
Weak
Weak
Operating income divided by interest expense
Optimal:
> 5x
|
0.88x
Weak
Weak
Operating income divided by interest expense
Optimal:
> 5x
|
| Net Debt (USD) | $1.22B | $2.44B | $2.36B | — | — |
| Debt / EBITDA (x) |
20.28x
Weak
Weak
Debt relative to earnings before interest, taxes, depreciation
Optimal:
< 2x
|
16.54x
Weak
Weak
Debt relative to earnings before interest, taxes, depreciation
Optimal:
< 2x
|
— | — | — |
| Metric | Q2 FY2026 Jun 30, 2026 10-Q ↗ | Q1 FY2026 Mar 31, 2026 10-Q ↗ | Q4 FY2025 Dec 31, 2025 10-Q ↗ | Q2 FY2025 Jun 30, 2025 10-Q ↗ | Q1 FY2025 Mar 31, 2025 10-Q ↗ |
|---|---|---|---|---|---|
| Sales/Revenue/Turnover (USD) | $500.73M | $458.86M | — | $400.44M | $380.08M |
| Depreciation Expense (USD) | $52.03M | $51.53M | — | $49.10M | $48.99M |
| Net Income, GAAP (USD) | $53.31M | $53.31M | — | $-4.32M | $-4.32M |
| Operating Cash Flow (USD) | $137.88M | $36.47M | — | $47.84M | $20.76M |
Secondary lens
Benchmark Lens
Compare ARXS against peers after checking the statement evidence.
Open lens
Benchmark Lens
Compare ARXS against peers after checking the statement evidence.
Compare ARXS with peers
Stack ARXS against similar companies across every metric on this page.
north_east Open comparisonbar_chart Data from SEC EDGAR XBRL filings
Synced 1 week ago